0
Signin
countryflagCA

888-969-2592

RY 156.04 -0.032% TD 79.81 -0.4615% SHOP 99.81 0.9303% CNR 158.79 0.6401% ENB 53.84 0.4478% CP 111.87 0.8019% BMO 112.71 0.7419% TRI 225.62 0.396% CNQ 50.46 2.4777% BN 67.8 1.194% ATD 76.93 -1.0674% CSU 4321.5298 0.3257% BNS 67.27 1.3102% CM 78.76 1.5603% SU 54.66 -1.1037% TRP 62.42 1.2162% NGT 70.54 0.2558% WCN 251.32 0.3153% MFC 36.65 -0.0818% BCE 47.21 0.3187%

NeuPath Health Inc

Healthcare CA NPTH

0.18CAD
0.005(2.86%)

Last update at 2024-08-30T18:27:00Z

Day Range

0.170.18
LowHigh

52 Week Range

0.080.25
LowHigh

Fundamentals

  • Previous Close 0.17
  • Market Cap9.85M
  • Volume54500
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.27M
  • Revenue TTM65.37M
  • Revenue Per Share TTM1.22
  • Gross Profit TTM 10.82M
  • Diluted EPS TTM-0.04

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.08100M -3.24700M -4.86000M -5.39500M -
Minority interest 0.13M - - - -
Net income -4.16600M -3.23000M -5.05800M -5.31000M -
Selling general administrative 9.41M 9.93M 8.04M 8.17M -
Selling and marketing expenses - - - - -
Gross profit 10.82M 11.11M 9.72M 9.96M -
Reconciled depreciation 2.67M 3.08M 2.53M 2.48M -
Ebit -1.25600M -1.84100M -0.82000M -0.66100M -1.03800M
Ebitda -0.58400M 0.71M -0.86300M -0.97300M -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.25600M -1.84100M -0.82000M -0.66100M -
Other operating expenses - - - - -
Interest expense 0.83M 0.88M 1.47M 1.94M 0.00000M
Tax provision 0.19M -0.01700M 0.20M -0.08500M -
Interest income 0.02M 0.03M 0.05M 0.06M -
Net interest income -0.81000M -0.84200M -1.42200M -1.88200M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.19M -0.01700M 0.20M -0.08500M 0.07M
Total revenue 62.65M 60.86M 47.64M 49.64M -
Total operating expenses 63.91M 62.70M 48.46M 50.30M -
Cost of revenue 51.83M 49.75M 37.92M 39.68M -
Total other income expense net -2.01500M -0.56400M -2.61800M -2.85200M -
Discontinued operations - - - - -
Net income from continuing ops -4.27500M -3.23000M -5.05800M -5.31000M -
Net income applicable to common shares -4.16600M -3.23000M -5.05800M -5.31000M -5.31900M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 45.09M 51.34M 46.12M 37.99M -
Intangible assets 1.00M 3.05M 0.88M 1.73M -
Earning assets - - - - -
Other current assets 0.67M 0.99M 0.63M 0.61M 0.13M
Total liab 23.43M 25.51M 18.50M 28.22M -
Total stockholder equity 21.78M 25.83M 27.62M 9.77M -
Deferred long term liab - - - - -
Other current liab 0.43M 0.61M - 1.92M 1.73M
Common stock 39.92M 36.83M 32.83M 11.53M 9.07M
Capital stock 39.92M 36.83M 32.83M 11.53M -
Retained earnings -25.91500M -21.77100M -18.54100M -13.48300M -8.17300M
Other liab 0.03M 0.21M 0.06M 0.10M 0.69M
Good will 20.72M 20.72M 18.97M 18.97M -
Other assets 0.74M 0.61M 0.30M 0.43M -
Cash 1.52M 5.90M 10.85M 0.88M -
Cash and equivalents - - - - -
Total current liabilities 13.87M 13.71M 9.98M 18.04M 16.10M
Current deferred revenue - - - - -
Net debt 5.25M 2.50M - 13.12M -
Short term debt - - - - -
Short long term debt 3.09M 3.44M 3.09M 8.59M -
Short long term debt total - - - - -
Other stockholder equity 4.88M 9.16M 12.91M 11.65M 11.48M
Property plant equipment 11.54M 11.60M 6.63M 8.22M 3.88M
Total current assets 11.08M 15.37M 19.33M 8.65M 6.88M
Long term investments - - - - -
Net tangible assets 0.06M 2.06M 7.77M -10.92800M -10.63200M
Short term investments - - - - -
Net receivables 8.89M 8.47M 7.84M 7.15M 5.15M
Long term debt 3.67M 4.96M 4.91M 5.41M -
Inventory - - - - -
Accounts payable 8.80M 7.53M 5.61M 5.16M 4.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.74M 0.61M 0.30M 0.43M -
Deferred long term asset charges - - - - -
Non current assets total 34.01M 35.98M 26.79M 29.34M -
Capital lease obligations 7.40M 8.00M 4.67M 5.69M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.67200M -3.49900M 2.68M -0.27200M -
Change to liabilities 0.00000M 0.40M 0.36M 0.86M 0.56M
Total cashflows from investing activities -1.67200M -3.49900M 2.68M -0.27200M -8.11800M
Net borrowings -3.70300M -3.60500M -2.77600M -2.06500M 6.68M
Total cash from financing activities -3.45200M -3.36700M 7.93M 0.72M 7.86M
Change to operating activities 0.24M -0.15400M -0.75000M -0.41600M -0.33700M
Net income -4.16600M -3.23000M -5.05800M -5.31000M -5.31900M
Change in cash -4.38600M -4.94700M 9.97M -0.53900M -2.38700M
Begin period cash flow 5.90M 10.85M 0.88M 1.42M -
End period cash flow 1.52M 5.90M 10.85M 0.88M 1.42M
Total cash from operating activities 0.74M 1.92M -0.64600M -0.98600M -2.12600M
Issuance of capital stock - - 10.55M 2.63M -
Depreciation 2.67M 3.08M 2.53M 2.48M 1.28M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.42000M 0.49M -0.52100M -1.93300M -0.86200M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.25M 0.24M 1.35M 0.32M -0.11100M
Change to netincome 2.00M 0.89M 3.14M 3.32M 2.53M
Capital expenditures 1.23M 0.41M 0.04M 0.13M 0.57M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.24M 1.18M -1.25600M -1.48400M -
Stock based compensation 0.10M 0.52M 0.22M 0.07M -
Other non cash items 0.10M 0.64M 2.59M 1.69M -
Free cash flow -0.93400M 1.17M -0.74700M -1.11700M -

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NPTH
NeuPath Health Inc		 0.005 2.86% 0.18 - 6.64 0.15 0.44 0.29 9.33
KDA
KDA Group Inc		 0.02 8.16% 0.27 - - 458.88 2.87 461.75 11.09
PHA
Premier Health of America Inc		 -0.01 5.88% 0.16 - 37.04 0.27 1.48 0.56 8.61
NLH
Nova Leap Health Corp		 -0.02 7.69% 0.24 - 6.14 0.78 0.82 0.84 -129.1199
JNH
Jack Nathan Medical Corp		 -0.01 25.00% 0.03 - - 0.25 7.84 0.61 -1.8458

Reports Covered

Stock Research & News

View All

Profile

NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers. The company is headquartered in Mississauga, Canada.

NeuPath Health Inc

6400 Millcreek Drive, Mississauga, ON, Canada, L5N 3E7

Key Executives

Name Title Year Born
Mr. Joseph Andrew Walewicz MBA Interim CEO & Director 1969
Mr. Jeff Zygouras C.A., CPA CFO & Corp. Sec. NA
Bjorn Thies VP of People & Culture NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.